Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
First Claim
1. A pharmaceutical reservoir electrode for use in iontotherapeutic delivery of a pharmaceutical which is ionized and is contained therein, comprising:
- a) a housing for said electrode;
b) a first chamber which contains an electrolytic solution to permit said iontotherapeutic delivery to take place and having present therein ion exchange granules which inhibit increased ionic content through ion generation in the electrode in the first chamber as the iontotherapeutic process takes place;
c) an electrical terminus to contact electrically the electrolytic solution contained in said first chamber;
d) a second chamber for receiving a unit dose of said ionized pharmaceutical, ande) a permselective membrane separating said first and second chambers, said membrane characterized by having pores with sufficiently low permeability to inhibit substantial passage of said ionized pharmaceutical present in said second chamber into said first chamber, said permselective membrane being substantially free of ion exchange sites.
1 Assignment
0 Petitions
Accused Products
Abstract
Provided are reservoir electrodes for iontotherapeutic devices which have two chambers; the first chamber is electrically connected to the iontotherapeutic device and is designed to contain electrolytic solution and the second chamber has ionized pharmaceutical dissolved in electrolytic solution. The two chambers are separated by a permselective membrane. The first chamber has means to inhibit increase in ionic content caused by the operation of the iontotherapeutic device. Also provided are unit dose forms adapted for insertion into the reservoir electrodes. The dose unit forms are made of crosslinked polymer and contain ionizable pharmaceutical which is released for absorption during operation of the iontotherapeutic process. Also provided are novel iontotherapeutic devices and processes.
-
Citations
21 Claims
-
1. A pharmaceutical reservoir electrode for use in iontotherapeutic delivery of a pharmaceutical which is ionized and is contained therein, comprising:
-
a) a housing for said electrode; b) a first chamber which contains an electrolytic solution to permit said iontotherapeutic delivery to take place and having present therein ion exchange granules which inhibit increased ionic content through ion generation in the electrode in the first chamber as the iontotherapeutic process takes place; c) an electrical terminus to contact electrically the electrolytic solution contained in said first chamber; d) a second chamber for receiving a unit dose of said ionized pharmaceutical, and e) a permselective membrane separating said first and second chambers, said membrane characterized by having pores with sufficiently low permeability to inhibit substantial passage of said ionized pharmaceutical present in said second chamber into said first chamber, said permselective membrane being substantially free of ion exchange sites. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)
-
-
14. A sterile unit dose adapted to be removably inserted into the receiving chamber of a reservoir electrode of a transdermal periodic iontotherapeutic system, said unit dose to be used in electrical contact with intact skin to be iontotherapeutically treated to administer transdermally a systemically effective dose amount of an effective and transdermally absorbable amount of an ionized pharmaceutical;
- said unit dose containing a sterile solution of said ionized pharmaceutical dispersed therein having an iontotherapeutically effective and physiologically acceptable pH at least about one pH unit lower or higher than the pKa or isoelectric point of said pharmaceutical;
said unit dose adapted to permit said pharmaceutical to be released upon application to the reservoir electrode of an effective DC current;
said unit dose made of a crosslinked, hydrophilic polymer and being dimensionally stable. - View Dependent Claims (15, 16, 17, 18, 19, 20, 21)
- said unit dose containing a sterile solution of said ionized pharmaceutical dispersed therein having an iontotherapeutically effective and physiologically acceptable pH at least about one pH unit lower or higher than the pKa or isoelectric point of said pharmaceutical;
Specification